Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,457–3,464 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Rafael Holdings Inc. Class B CPI-613 (devimistat) + hydroxychloroquine Relapsed or Refractory Myelodysplastic Syndrome (MDS) Phase 2 Trial Completed Intravenous and oral Hematology
Rafael Holdings Inc. Class B CPI-613 (devimistat) + mFOLFIRINOX Locally advanced pancreatic cancer Phase 2 Trial Discontinued Intravenous Oncology
Rallybio Corporation RLYB212 Fetal and neonatal alloimmune thrombocytopenia (FNAIT) Phase 2 Trial Discontinued Intravenous Hematology
Rapport Therapeutics Inc. RAP-219 Bipolar mania Phase 2a Trial Planned Oral Psychiatric
Rapport Therapeutics Inc. RAP-219 - (FOS) Focal epilepsy Phase 2a Data Released oral Neurology
Rapport Therapeutics Inc. RAP-219 - (PET) Drug-resistant focal epilepsy Phase 2a Type Meeting Intravenous Neurology
RAPT Therapeutics Inc. RPT904 - (prestIgE) Food allergy Phase 2b IND Clearance Subcutaneous Immunology
RAPT Therapeutics Inc. RPT904 - (prestIgE) Food allergy Phase 2b IND Clearance Subcutaneous Immunology